Associations between changes in glucagon-like peptide-1 and bodyweight reduction in patients receiving acarbose or metformin treatment
Author:
Affiliation:
1. Department of Endocrinology; China-Japan Friendship Hospital; Beijing China
2. Graduate School of Peking Union Medical College; Chinese Academy of Medical Sciences; Beijing China
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12486/fullpdf
Reference57 articles.
1. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes [published erratum appears in http://www.nejm.org/doi/full/10.1056/NEJMx140022];The Look AHEAD Research Group;N Engl J Med,2013
2. GLP-1 based therapeutics: Simultaneously combating T2DM and obesity;Heppner;Front Neurosci.,2015
3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998
4. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44);Holman;Diabetes Care,1999
5. Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus;Coniff;Am J Med.,1995
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Secondary analysis of newly diagnosed type 2 diabetes subgroups and treatment responses in the MARCH cohort;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01
2. Acarbose protects from central and peripheral metabolic imbalance induced by benzene exposure;Brain, Behavior, and Immunity;2020-10
3. Acarbose Protects From Central and Peripheral Metabolic Imbalance Induced by Benzene Exposure;2020-03-20
4. Physiology of the Incretin Hormones, GIP and GLP ‐1—Regulation of Release and Posttranslational Modifications;Comprehensive Physiology;2019-09-19
5. MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin;Archives of Medical Science;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3